Medical News

RSS

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

HealthSouth Corporation today announced that its Board of Directors has authorized the Company to amend its bylaws to adopt procedures relating to shareholder nominations for the election of directors.

26 Oct 2009

German based LIFEBRIDGE AG receives FDA clearance for mobile LIFEBRIDGE

German based LIFEBRIDGE AG has received clearance from the U.S. Food and Drug Administration (FDA) for a compact, lightweight, mobile heart-lung machine, a first for any manufacturer worldwide.

26 Oct 2009

Dey Pharma launches EpiPen Auto-Injector

Dey Pharma, L.P., a subsidiary of Mylan Inc., today launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation EpiPen Auto-Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto-Injector with several new, user-friendly features, including being the only auto-injector with needle-protection before and after use.

26 Oct 2009

Third-quarter financial results announced by Roper Industries

Roper Industries, Inc. reported financial results for the third quarter ended September 30, 2009.

26 Oct 2009

American Heart Association joins international organizations to fight the global threat of stroke

During this year's observance of "World Stroke Day," Thursday, October 29, the American Heart Association and its division, the American Stroke Association, will join international organizations with a unified message about the global threat of stroke.

26 Oct 2009

Tru-flo urinary catheter valve from ProtekMed

ProtekMed has launched the Tru-flo(TM) urinary catheter valve, an innovative and economical alternative to the standard tube and bag system prescribed by most urologists today.

26 Oct 2009

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.

26 Oct 2009

First physician affiliated with Renaissance Health Systems goes live with PWeR

The Quantum Group, Inc. announced today that the first physician affiliated with Quantum subsidiary Renaissance Health Systems has “gone live” with PWeR™ (Personal Wellness electronic Record™), the one patient, one record™ electronic medical record platform offered by Quantum Innovations, Inc.

26 Oct 2009

EMG and NCS reports performed by 'non-prequalified' physicians are found to be unreliable

In a recent study of workers’ compensation injury cases, Electromyography (EMG) and Nerve Conduction Studies (NCSs), which were performed by physicians who were not evaluated and pre-determined to meet a certain level of quality, were discovered to be highly unreliable.

26 Oct 2009

Pritzker Olsen to represent 3-year-old child sickened with an E. coli O157:H7 infection

Pritzker Olsen law firm has been retained to represent a 3-year-old child sickened with an E. coli O157:H7 infection and hemolytic uremic syndrome. The child is believed to have contracted the illness at a local apple orchard/ petting zoo in the Twin Cities (MN) area. Preliminary testing indicates that the genetic fingerprint of the E .coli O157:H7 obtained from the child’s stool sample matches the genetic fingerprint of E. coli from llama feces tested at the petting zoo.

26 Oct 2009

Cel Sci completes its production facility for Multikine Phase III clinical trial

BioMedReports, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, was given an exclusive tour of CEL-SCI Corporation's, new, state-of-the-art manufacturing facility near Baltimore, MD where the potentially ground breaking cancer immunotherapy treatment, Multikine, will be manufactured to support an upcoming Phase III clinical trial.

26 Oct 2009

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.

26 Oct 2009

Overview of Compugen’s DAC Blockers Platform presented at Fifth Peptide Engineering Meeting

Speaking today in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. project manager Dr. Yossef Kliger provided an overview of Compugen’s DAC Blockers Platform and reviewed disease model data for selected product candidates.

26 Oct 2009

Winners of the EDCTP Award For Outstanding African Scientist

The European & Developing Countries Clinical Trials Partnership (EDCTP) has given its Awards for Outstanding African Scientist to Dr Alexis Nzila and Dr Dominique Pepper.

26 Oct 2009

Preliminary results for fiscal 2010 first quarter released by Rural/Metro

Rural/Metro Corporation, a leading provider of ambulance and private fire protection services, announced preliminary, unaudited results today for its fiscal 2010 first quarter.

26 Oct 2009

Anti-viral drug development programs progress successfully, reports NanoViricides

NanoViricides, Inc. (the "Company"), reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in stock price and associated volatility.

26 Oct 2009

CB&I signs definitive agreement with H2Gen Innovations to acquire PSA technology

CB&I (NYSE:CBI) announced today that it has entered into a definitive agreement with H2Gen Innovations, Inc., to acquire the Mars modularized Pressure Swing Adsorption (PSA) technology.

26 Oct 2009

Sunquest Information Systems achieves best ever results in fiscal year 2009 ending May 31

Sunquest Information Systems, Inc., a privately held market leader in laboratory and diagnostic information systems, today announced that the Fiscal Year 2009 ending May 31 was its most successful in the 30 year history of the company. This success is continuing into the new fiscal year, as sales orders for first quarter FY 2010, ending August 31, 2009 increased more than 30 percent compared to the same quarter a year ago.

26 Oct 2009

First Edition: October 26, 2009

Several Democratic senators voiced optimism on Sunday that Congress would pass a health care bill containing at least the germ of a government-run insurance program. Their expectations were grudgingly seconded by Senator John McCain, the Republican presidential candidate in 2008 (The New York Times).

26 Oct 2009

Insure.com renamed as Life Quotes; Nasdaq ticker symbol to be changed to QUOT

Insure.com, Inc. (Nasdaq: NSUR), announced today that it has completed its corporate name change to Life Quotes, Inc. The Company also announced that its Nasdaq ticker symbol will be changed to QUOT effective with the opening of the market on October 28, 2009.

26 Oct 2009

Medical News

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

German based LIFEBRIDGE AG receives FDA clearance for mobile LIFEBRIDGE

Dey Pharma launches EpiPen Auto-Injector

Third-quarter financial results announced by Roper Industries

American Heart Association joins international organizations to fight the global threat of stroke

Tru-flo urinary catheter valve from ProtekMed

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

First physician affiliated with Renaissance Health Systems goes live with PWeR

EMG and NCS reports performed by 'non-prequalified' physicians are found to be unreliable

Pritzker Olsen to represent 3-year-old child sickened with an E. coli O157:H7 infection

Cel Sci completes its production facility for Multikine Phase III clinical trial

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Overview of Compugen’s DAC Blockers Platform presented at Fifth Peptide Engineering Meeting

Winners of the EDCTP Award For Outstanding African Scientist

Preliminary results for fiscal 2010 first quarter released by Rural/Metro

Anti-viral drug development programs progress successfully, reports NanoViricides

CB&I signs definitive agreement with H2Gen Innovations to acquire PSA technology

Sunquest Information Systems achieves best ever results in fiscal year 2009 ending May 31

First Edition: October 26, 2009

Insure.com renamed as Life Quotes; Nasdaq ticker symbol to be changed to QUOT

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News